139 related articles for article (PubMed ID: 19386580)
1. Novel variants of muscle calpain 3 identified in human melanoma cells: cisplatin-induced changes in vitro and differential expression in melanocytic lesions.
Moretti D; Del Bello B; Cosci E; Biagioli M; Miracco C; Maellaro E
Carcinogenesis; 2009 Jun; 30(6):960-7. PubMed ID: 19386580
[TBL] [Abstract][Full Text] [Related]
2. Calpain-3 impairs cell proliferation and stimulates oxidative stress-mediated cell death in melanoma cells.
Moretti D; Del Bello B; Allavena G; Corti A; Signorini C; Maellaro E
PLoS One; 2015; 10(2):e0117258. PubMed ID: 25658320
[TBL] [Abstract][Full Text] [Related]
3. Cross-talk between calpain and caspase-3/-7 in cisplatin-induced apoptosis of melanoma cells: a major role of calpain inhibition in cell death protection and p53 status.
Del Bello B; Moretti D; Gamberucci A; Maellaro E
Oncogene; 2007 Apr; 26(19):2717-26. PubMed ID: 17130844
[TBL] [Abstract][Full Text] [Related]
4. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor protein and mRNA expression in cutaneous melanocytic tumours.
Miracco C; De Nisi MC; Arcuri F; Cosci E; Pacenti L; Toscano M; Lalinga AV; Biagioli M; Rubegni P; Vatti R; Maellaro E; Del Bello B; Massi D; Luzi P; Tosi P
Int J Oncol; 2006 Feb; 28(2):345-52. PubMed ID: 16391788
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression.
de Vries TJ; Quax PH; Denijn M; Verrijp KN; Verheijen JH; Verspaget HW; Weidle UH; Ruiter DJ; van Muijen GN
Am J Pathol; 1994 Jan; 144(1):70-81. PubMed ID: 8291613
[TBL] [Abstract][Full Text] [Related]
7. Insertion sequence 1 from calpain-3 is functional in calpain-2 as an internal propeptide.
McCartney CE; Ye Q; Campbell RL; Davies PL
J Biol Chem; 2018 Nov; 293(46):17716-17730. PubMed ID: 30254072
[TBL] [Abstract][Full Text] [Related]
8. Cloning and expression of mRNA for calpain Lp82 from rat lens: splice variant of p94.
Ma H; Fukiage C; Azuma M; Shearer TR
Invest Ophthalmol Vis Sci; 1998 Feb; 39(2):454-61. PubMed ID: 9478008
[TBL] [Abstract][Full Text] [Related]
9. ERK1/2 is highly phosphorylated in melanoma metastases and protects melanoma cells from cisplatin-mediated apoptosis.
Mirmohammadsadegh A; Mota R; Gustrau A; Hassan M; Nambiar S; Marini A; Bojar H; Tannapfel A; Hengge UR
J Invest Dermatol; 2007 Sep; 127(9):2207-15. PubMed ID: 17508026
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of cytoplasmic p27 expression in human melanoma.
Chen G; Cheng Y; Zhang Z; Martinka M; Li G
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
[TBL] [Abstract][Full Text] [Related]
11. Calpains in muscle wasting.
Bartoli M; Richard I
Int J Biochem Cell Biol; 2005 Oct; 37(10):2115-33. PubMed ID: 16125114
[TBL] [Abstract][Full Text] [Related]
12. The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance.
Schittek B; Psenner K; Sauer B; Meier F; Iftner T; Garbe C
Int J Cancer; 2007 May; 120(10):2110-8. PubMed ID: 17266041
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of melanoma precursor lesions.
Wang Y; Rao U; Mascari R; Richards TJ; Panson AJ; Edington HD; Shipe-Spotloe JM; Donnelly SS; Kirkwood JM; Becker D
Cell Growth Differ; 1996 Dec; 7(12):1733-40. PubMed ID: 8959342
[TBL] [Abstract][Full Text] [Related]
14. Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma.
Prieto VG; Mourad-Zeidan AA; Melnikova V; Johnson MM; Lopez A; Diwan AH; Lazar AJ; Shen SS; Zhang PS; Reed JA; Gershenwald JE; Raz A; Bar-Eli M
Clin Cancer Res; 2006 Nov; 12(22):6709-15. PubMed ID: 17121890
[TBL] [Abstract][Full Text] [Related]
15. Proliferation, apoptosis, and survivin expression in a spectrum of melanocytic nevi.
Florell SR; Bowen AR; Hanks AN; Murphy KJ; Grossman D
J Cutan Pathol; 2005 Jan; 32(1):45-9. PubMed ID: 15660660
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of melanocytic tissue array reveals inverse correlation between activator protein-2alpha and protease-activated receptor-1 expression during melanoma progression.
Tellez CS; Davis DW; Prieto VG; Gershenwald JE; Johnson MM; McCarty MF; Bar-Eli M
J Invest Dermatol; 2007 Feb; 127(2):387-93. PubMed ID: 16946713
[TBL] [Abstract][Full Text] [Related]
17. Nucleolin protein expression in cutaneous melanocytic lesions.
Mourmouras V; Cevenini G; Cosci E; Epistolato MC; Biagioli M; Barbagli L; Luzi P; Mannucci S; Miracco C
J Cutan Pathol; 2009 Jun; 36(6):637-46. PubMed ID: 19515042
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin Induces Apoptosis Through the Endoplasmic Reticulum-mediated, Calpain 1 Pathway in Triple-negative Breast Cancer Cells.
Al-Bahlani SM; Al-Bulushi KH; Al-Alawi ZM; Al-Abri NY; Al-Hadidi ZR; Al-Rawahi SS
Clin Breast Cancer; 2017 Jun; 17(3):e103-e112. PubMed ID: 28089626
[TBL] [Abstract][Full Text] [Related]
19. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
20. Nuclear ING2 expression is reduced in human cutaneous melanomas.
Lu F; Dai DL; Martinka M; Ho V; Li G
Br J Cancer; 2006 Jul; 95(1):80-6. PubMed ID: 16755297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
